后 COVID-19 定义和临床编码实践的特征:纵向研究。

Monika Maripuri, Andrew Dey, Jacqueline Honerlaw, Chuan Hong, Yuk-Lam Ho, Vidisha Tanukonda, Alicia W Chen, Vidul Ayakulangara Panickan, Xuan Wang, Harrison G Zhang, Doris Yang, Malarkodi Jebathilagam Samayamuthu, Michele Morris, Shyam Visweswaran, Brendin Beaulieu-Jones, Rachel Ramoni, Sumitra Muralidhar, J Michael Gaziano, Katherine Liao, Zongqi Xia, Gabriel A Brat, Tianxi Cai, Kelly Cho
{"title":"后 COVID-19 定义和临床编码实践的特征:纵向研究。","authors":"Monika Maripuri, Andrew Dey, Jacqueline Honerlaw, Chuan Hong, Yuk-Lam Ho, Vidisha Tanukonda, Alicia W Chen, Vidul Ayakulangara Panickan, Xuan Wang, Harrison G Zhang, Doris Yang, Malarkodi Jebathilagam Samayamuthu, Michele Morris, Shyam Visweswaran, Brendin Beaulieu-Jones, Rachel Ramoni, Sumitra Muralidhar, J Michael Gaziano, Katherine Liao, Zongqi Xia, Gabriel A Brat, Tianxi Cai, Kelly Cho","doi":"10.2196/53445","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-COVID-19 condition (colloquially known as \"long COVID-19\") characterized as postacute sequelae of SARS-CoV-2 has no universal clinical case definition. Recent efforts have focused on understanding long COVID-19 symptoms, and electronic health record (EHR) data provide a unique resource for understanding this condition. The introduction of the International Classification of Diseases, Tenth Revision (ICD-10) code U09.9 for \"Post COVID-19 condition, unspecified\" to identify patients with long COVID-19 has provided a method of evaluating this condition in EHRs; however, the accuracy of this code is unclear.</p><p><strong>Objective: </strong>This study aimed to characterize the utility and accuracy of the U09.9 code across 3 health care systems-the Veterans Health Administration, the Beth Israel Deaconess Medical Center, and the University of Pittsburgh Medical Center-against patients identified with long COVID-19 via a chart review by operationalizing the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) definitions.</p><p><strong>Methods: </strong>Patients who were COVID-19 positive with either a U07.1 ICD-10 code or positive polymerase chain reaction test within these health care systems were identified for chart review. Among this cohort, we sampled patients based on two approaches: (1) with a U09.9 code and (2) without a U09.9 code but with a new onset long COVID-19-related ICD-10 code, which allows us to assess the sensitivity of the U09.9 code. To operationalize the long COVID-19 definition based on health agency guidelines, symptoms were grouped into a \"core\" cluster of 11 commonly reported symptoms among patients with long COVID-19 and an extended cluster that captured all other symptoms by disease domain. Patients having ≥2 symptoms persisting for ≥60 days that were new onset after their COVID-19 infection, with ≥1 symptom in the core cluster, were labeled as having long COVID-19 per chart review. The code's performance was compared across 3 health care systems and across different time periods of the pandemic.</p><p><strong>Results: </strong>Overall, 900 patient charts were reviewed across 3 health care systems. The prevalence of long COVID-19 among the cohort with the U09.9 ICD-10 code based on the operationalized WHO definition was between 23.2% and 62.4% across these health care systems. We also evaluated a less stringent version of the WHO definition and the CDC definition and observed an increase in the prevalence of long COVID-19 at all 3 health care systems.</p><p><strong>Conclusions: </strong>This is one of the first studies to evaluate the U09.9 code against a clinical case definition for long COVID-19, as well as the first to apply this definition to EHR data using a chart review approach on a nationwide cohort across multiple health care systems. This chart review approach can be implemented at other EHR systems to further evaluate the utility and performance of the U09.9 code.</p>","PeriodicalId":74345,"journal":{"name":"Online journal of public health informatics","volume":"16 ","pages":"e53445"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11073632/pdf/","citationCount":"0","resultStr":"{\"title\":\"Characterization of Post-COVID-19 Definitions and Clinical Coding Practices: Longitudinal Study.\",\"authors\":\"Monika Maripuri, Andrew Dey, Jacqueline Honerlaw, Chuan Hong, Yuk-Lam Ho, Vidisha Tanukonda, Alicia W Chen, Vidul Ayakulangara Panickan, Xuan Wang, Harrison G Zhang, Doris Yang, Malarkodi Jebathilagam Samayamuthu, Michele Morris, Shyam Visweswaran, Brendin Beaulieu-Jones, Rachel Ramoni, Sumitra Muralidhar, J Michael Gaziano, Katherine Liao, Zongqi Xia, Gabriel A Brat, Tianxi Cai, Kelly Cho\",\"doi\":\"10.2196/53445\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Post-COVID-19 condition (colloquially known as \\\"long COVID-19\\\") characterized as postacute sequelae of SARS-CoV-2 has no universal clinical case definition. Recent efforts have focused on understanding long COVID-19 symptoms, and electronic health record (EHR) data provide a unique resource for understanding this condition. The introduction of the International Classification of Diseases, Tenth Revision (ICD-10) code U09.9 for \\\"Post COVID-19 condition, unspecified\\\" to identify patients with long COVID-19 has provided a method of evaluating this condition in EHRs; however, the accuracy of this code is unclear.</p><p><strong>Objective: </strong>This study aimed to characterize the utility and accuracy of the U09.9 code across 3 health care systems-the Veterans Health Administration, the Beth Israel Deaconess Medical Center, and the University of Pittsburgh Medical Center-against patients identified with long COVID-19 via a chart review by operationalizing the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) definitions.</p><p><strong>Methods: </strong>Patients who were COVID-19 positive with either a U07.1 ICD-10 code or positive polymerase chain reaction test within these health care systems were identified for chart review. Among this cohort, we sampled patients based on two approaches: (1) with a U09.9 code and (2) without a U09.9 code but with a new onset long COVID-19-related ICD-10 code, which allows us to assess the sensitivity of the U09.9 code. To operationalize the long COVID-19 definition based on health agency guidelines, symptoms were grouped into a \\\"core\\\" cluster of 11 commonly reported symptoms among patients with long COVID-19 and an extended cluster that captured all other symptoms by disease domain. Patients having ≥2 symptoms persisting for ≥60 days that were new onset after their COVID-19 infection, with ≥1 symptom in the core cluster, were labeled as having long COVID-19 per chart review. The code's performance was compared across 3 health care systems and across different time periods of the pandemic.</p><p><strong>Results: </strong>Overall, 900 patient charts were reviewed across 3 health care systems. The prevalence of long COVID-19 among the cohort with the U09.9 ICD-10 code based on the operationalized WHO definition was between 23.2% and 62.4% across these health care systems. We also evaluated a less stringent version of the WHO definition and the CDC definition and observed an increase in the prevalence of long COVID-19 at all 3 health care systems.</p><p><strong>Conclusions: </strong>This is one of the first studies to evaluate the U09.9 code against a clinical case definition for long COVID-19, as well as the first to apply this definition to EHR data using a chart review approach on a nationwide cohort across multiple health care systems. This chart review approach can be implemented at other EHR systems to further evaluate the utility and performance of the U09.9 code.</p>\",\"PeriodicalId\":74345,\"journal\":{\"name\":\"Online journal of public health informatics\",\"volume\":\"16 \",\"pages\":\"e53445\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11073632/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Online journal of public health informatics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2196/53445\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Online journal of public health informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/53445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:以 SARS-CoV-2 后遗症为特征的 COVID-19 后症状(俗称 "长 COVID-19")并没有统一的临床病例定义。最近的工作重点是了解长 COVID-19 症状,电子健康记录 (EHR) 数据为了解这种病症提供了独特的资源。国际疾病分类第十版》(ICD-10)引入了 U09.9 编码 "COVID-19 后症状,未指定 "来识别长 COVID-19 患者,这为在电子病历中评估该症状提供了一种方法;然而,该编码的准确性尚不明确:本研究旨在通过对世界卫生组织(WHO)和美国疾病控制与预防中心(CDC)的定义进行操作,对通过病历审查发现的长 COVID-19 患者在 3 个医疗系统(退伍军人健康管理局、贝斯以色列女执事医疗中心和匹兹堡大学医疗中心)中使用 U09.9 代码的实用性和准确性进行描述:我们对这些医疗系统中 COVID-19 阳性且 ICD-10 编码为 U07.1 或聚合酶链反应检测呈阳性的患者进行了病历审查。在这一群体中,我们根据两种方法对患者进行了抽样:(1) 有 U09.9 编码的患者;(2) 没有 U09.9 编码但有新发病长 COVID-19 相关 ICD-10 编码的患者,这样我们就可以评估 U09.9 编码的敏感性。为了在卫生机构指南的基础上将长COVID-19定义具体化,我们将长COVID-19患者的症状分为由11个常见症状组成的 "核心 "群组和一个扩展群组,前者按疾病领域涵盖所有其他症状。根据病历审查,如果患者在感染 COVID-19 后有≥2 个症状持续≥60 天且为新发症状,且核心症状群中有≥1 个症状,则标记为长 COVID-19 患者。该代码的性能在 3 个医疗系统和大流行的不同时期进行了比较:结果:3 个医疗系统共审查了 900 份病历。在这些医疗系统中,根据世界卫生组织的操作化定义使用 U09.9 ICD-10 代码的人群中,长 COVID-19 的流行率介于 23.2% 和 62.4% 之间。我们还评估了世卫组织定义和疾病预防控制中心定义的较宽松版本,并观察到在所有 3 个医疗系统中,长 COVID-19 的患病率均有所上升:这是首次根据长COVID-19的临床病例定义评估U09.9代码的研究之一,也是首次在多个医疗系统的全国性队列中使用病历审查方法将该定义应用于电子病历数据的研究之一。这种病历审查方法可在其他电子病历系统中实施,以进一步评估 U09.9 代码的效用和性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Characterization of Post-COVID-19 Definitions and Clinical Coding Practices: Longitudinal Study.

Background: Post-COVID-19 condition (colloquially known as "long COVID-19") characterized as postacute sequelae of SARS-CoV-2 has no universal clinical case definition. Recent efforts have focused on understanding long COVID-19 symptoms, and electronic health record (EHR) data provide a unique resource for understanding this condition. The introduction of the International Classification of Diseases, Tenth Revision (ICD-10) code U09.9 for "Post COVID-19 condition, unspecified" to identify patients with long COVID-19 has provided a method of evaluating this condition in EHRs; however, the accuracy of this code is unclear.

Objective: This study aimed to characterize the utility and accuracy of the U09.9 code across 3 health care systems-the Veterans Health Administration, the Beth Israel Deaconess Medical Center, and the University of Pittsburgh Medical Center-against patients identified with long COVID-19 via a chart review by operationalizing the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) definitions.

Methods: Patients who were COVID-19 positive with either a U07.1 ICD-10 code or positive polymerase chain reaction test within these health care systems were identified for chart review. Among this cohort, we sampled patients based on two approaches: (1) with a U09.9 code and (2) without a U09.9 code but with a new onset long COVID-19-related ICD-10 code, which allows us to assess the sensitivity of the U09.9 code. To operationalize the long COVID-19 definition based on health agency guidelines, symptoms were grouped into a "core" cluster of 11 commonly reported symptoms among patients with long COVID-19 and an extended cluster that captured all other symptoms by disease domain. Patients having ≥2 symptoms persisting for ≥60 days that were new onset after their COVID-19 infection, with ≥1 symptom in the core cluster, were labeled as having long COVID-19 per chart review. The code's performance was compared across 3 health care systems and across different time periods of the pandemic.

Results: Overall, 900 patient charts were reviewed across 3 health care systems. The prevalence of long COVID-19 among the cohort with the U09.9 ICD-10 code based on the operationalized WHO definition was between 23.2% and 62.4% across these health care systems. We also evaluated a less stringent version of the WHO definition and the CDC definition and observed an increase in the prevalence of long COVID-19 at all 3 health care systems.

Conclusions: This is one of the first studies to evaluate the U09.9 code against a clinical case definition for long COVID-19, as well as the first to apply this definition to EHR data using a chart review approach on a nationwide cohort across multiple health care systems. This chart review approach can be implemented at other EHR systems to further evaluate the utility and performance of the U09.9 code.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信